Please assess the completion status of the following clinical trial:

Trial Title: Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* patients with acute infarction or patients with acute infarction requiring reperfusion treatment or patients with chronic ischemic occlusion~* Karnofsky ≥ 80%~* signed informed consent~Exclusion Criteria:~* pregnancy, breastfeeding~* claustrophobia~* contra-indication to adenosine administration~* lack of discernment to sign informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- acute infarction (Type: OTHER): patients will have a 82-Rb and a 68Ga-NODAGA-RGD PET/CT at 1, 4 and 12 weeks after cardiac event
- acute infarction requiring reperfusion (Type: OTHER): patients will have a 82-Rb and a 68Ga-NODAGA-RGD PET/CT at 1, 4 and 12 weeks after cardiac event
- chronic ischemic occlusion (Type: OTHER): patients will have a 82-Rb and a 68Ga-NODAGA-RGD PET/CT before and 2 months after reperfusion treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).